Write in a clean editor, then format for Canadian Journal of Respiratory Critical Care and Sleep Medicine in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Canadian Journal of Respiratory Critical Care and Sleep Medicine is a peer-reviewed journal published by Taylor & Francis, covering Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Asthma and respiratory diseases.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Canadian Journal of Respiratory Critical Care and Sleep Medicine 12 (3): 45–58.
Formats any DOI in Canadian Journal of Respiratory Critical Care and Sleep Medicine style. No sign-up. |
| Publishes research in | Chronic Obstructive Pulmonary Disease (COPD) Research Respiratory Support and Mechanisms Asthma and respiratory diseases Respiratory and Cough-Related Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| ISSN | 2474-5332 |
| Citation impact (2-yr) | 0.23 |
| h-index | 20 |
| i10-index | 47 |
| Total citations | 1,761 |
| Top institutions publishing here | University of Toronto |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
In this guideline update, we highlight important and new findings related to pharmacological therapy of chronic obstructive pulmonary disease (COPD) that should change clinical practice and improve disease management. We present updated evidence, recommendations and expert clinical remarks on maintenance pharmacotherapy in patients with stable COPD. The diagnosis and nonpharmacological therapy of COPD are out-of-scope…
This document incorporates recommendations from the 2021 Canadian Thoracic Society (CTS) Guideline – A Focused Update on the Management of Very Mild and Mild Asthma1 with previous statements and re...
Over the last 30 to 40 years, improvements in technology, as well as changing clinical practice regarding the appropriateness of long-term ventilation in patients with “non-curable” disorders, have resulted in increasing numbers of children surviving what were previously considered fatal conditions. This has come but at the expense of requiring ongoing, long-term prolonged mechanical ventilation…
RATIONALE: While severe asthma affects approximately 5% of all individuals with asthma, this small minority of individuals accounts for a large proportion of the asthma-related costs. Greater understanding of the pathophysiology of asthma combined with the emergence of novel biologic therapies for severe asthma supported the need for a thorough review of the diagnosis, investigation,…
RATIONALE: Since the last published Canadian Thoracic Society (CTS) COPD guideline in 2007 and the 2008 update – highlights for primary care, many new clinical trials have challenged COPD treatment practices. The current Canadian position statement provides the reader with an update on pharmacotherapy of patients with COPD as reviewed by the CTS.OBJECTIVES: The objectives…
